TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yr (Emma Courtroom/Bloomberg)

TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yr (Emma Courtroom/Bloomberg)

by

[ad_1]

Emma Courtroom / Bloomberg:

TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yr  —  – TrialSpark expands from medical trials into growing medication  — Firm raised $156 million, is valued at greater than $1 billion


[ad_2]

Source

Leave a Comment